Owner Scorecard


← All companies ← MDGL Manual MDLZ → ← MBOT Medical Devices & Equipment MDT →

MDLN, Medline Inc.

Medical Devices & Equipment capital-intensive

Medline Inc. is the largest provider of medical-surgical products and supply chain solutions serving all points of care, based on total net sales of med-surg products.

Through our two segments, we offer approximately 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products.

We distribute these products through our expansive network o f glob al distribution facilities and our owne d fleet of MedTrans trucks.

Latest annual: FY2025 10-K
MDLN · Medline Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$28.4B
+11.5% YoY
Vital signs · TTM, with 3-yr average
Revenue $29.1B 3-yr avg $25.7B
Gross margin 26% 3-yr avg 26%
Operating margin 7.1% 3-yr avg 7.2%
ROIC 8% 3-yr avg 10%
Owner-earnings margin 4% 3-yr avg 5%
Free cash flow margin 4% 3-yr avg 5%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What moves the needle
Gross margin has run about 26% and operating margin about 7.8% through the cycle, a solid spread between what it charges and what the product costs to make. That margin has held in a narrow 5.4%–8.4% band over the years, so steadiness itself is the evidence — the lever is unit growth and cost discipline, not a moving line. Inventory runs near 17% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2023–2025

realized figures from each filing · older years to the left
2023’232024’242025’25TTMTTMMar 2026
Income statement
$23.2B$25.5B$28.4B$29.1BRevenueRevenue
25%27%26%26%Gross marginGross mgn
17%16%16%16%SG&A / revenueSG&A/rev
0%0%0%0%R&D / revenueR&D/rev
$1.3B$2.1B$2.2B$2.1BOperating incomeOp. inc.
5.4%8.4%7.8%7.1%Operating marginOp. mgn
$234M$1.2B$1.2B$972MNet incomeNet inc.
11%4%7%12%Effective tax rateTax rate
Cash flow & returns
$1.7B$1.8B$1.7B$1.5BOperating cash flowOp. cash
$951M$977M$1.0B$1.0BDepreciationDeprec.
$422M($432M)($502M)($596M)Working capital & otherWC & other
$275M$354M$447M$445MCapexCapex
1.2%1.4%1.6%1.5%Capex / revenueCapex/rev
$1.4B$1.4B$1.3B$1.0BOwner earningsOwner earn.
6.1%5.5%4.6%3.5%Owner earnings marginOE mgn
$1.4B$1.4B$1.3B$1.0BFree cash flowFCF
6.1%5.5%4.6%3.5%Free cash flow marginFCF mgn
$16M$1.1B$0$0AcquisitionsAcquis.
$0$20M$33MBuybacksBuybacks
10%8%ROICROIC
11%9%Return on equityROE
11%9%Retained to equityRetained/eq
Balance sheet
$1.6B$199M$1.9B$2.2BCash & investmentsCash+inv
$3.2B$3.5B$3.7BReceivablesReceiv.
$4.5B$4.8B$4.8BInventoryInvent.
$869M$961M$932MAccounts payablePayables
$6.8B$7.3B$7.5BOperating working capitalOper. WC
$8.3B$10.7B$11.2BCurrent assetsCur. assets
$2.4B$2.5B$2.5BCurrent liabilitiesCur. liab.
3.4×4.3×4.4×Current ratioCurr. ratio
$7.5B$8.1B$8.1B$8.1BGoodwillGoodwill
$36.0B$38.5B$39.0BTotal assetsAssets
$16.5B$12.6B$12.6BTotal debtDebt
$16.3B$10.6B$10.3BNet debt / (cash)Net debt
1.0×1.9×2.3×2.4×Interest coverageInt. cov.
$10.7B$11.3BShareholders’ equityEquity
0.3%0.2%0.3%0.3%Stock comp / revenueSBC/rev
Per share
810M825MShares out (diluted)Shares
$35.10$35.33Revenue / shareRev/sh
$1.43$1.18EPS (diluted)EPS
$1.60$1.25Owner earnings / shareOE/sh
$1.60$1.25Free cash flow / shareFCF/sh
$0.55$0.54Cap. spending / shareCapex/sh
$13.26$13.67Book value / shareBVPS

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Revenue+11.5%
    “Net sales for the U.S. business for the year ended December 31, 2025 increased $2,732 million, or 11.5%, to $26,479 million, compared to $23,747 million for the respective period in 2024, primarily driven by volume growth in Prime Vendor net sales, which for the year ended December 31, 2025 increased $2,000 million, or 12.5%, to $18,033 million, compared to $16,033 million for the respective period in 2024.”
    ✓ figure matches the filed record

The record, charted

FY2023–2025

Each measure over its full record; the current point and the worst year marked.

Gross margin
26%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$1.3Bowner earningsvs.$1.2Bnet incomelow FY2025

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetained

Each year's operating cash, by what management did with it: the mix, and how it drifts.

FY2023FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $1.2B of profit into $1.3B of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$1.2B
Owner earnings$1.3B · 5% of revenue
FY2025FY2024FY2023
Reported net income$1.2B$1.2B$234M
Depreciation & amortizationnon-cash charge added back+$1.0B+$977M+$951M
Stock-based compensationreal costnon-cash, but a real cost+$76M+$61M+$78M
Working capital & othertiming of cash in and out, other non-cash items−$502M−$432M+$422M
Cash from operations$1.7B$1.8B$1.7B
Capital expenditurecash put back in to keep running and to grow−$447M−$354M−$275M
Owner earnings$1.3B$1.4B$1.4B
Owner-earnings marginowner earnings ÷ revenue5%6%6%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $76M), owner earnings is nearer $1.2B.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Adequate
    Operating income $2.2B ÷ interest expense $945M
    What this means

    Comfortable in a normal year, but below the margin of safety Graham looked for. Worth checking how stable the coverage has been across a full cycle.

  • How heavy is the debt, net of cash? $10.6B · 4.8× operating profit
    Heavy net debt
    Cash $1.9B − debt $12.6B
    What this means

    Netting $1.9B of cash and short-term investments against $12.6B of debt leaves $10.6B owed, about 4.8× a year's operating profit (5.7× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 45 + DIO 83 − DPO 17 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Solid
    NOPAT $2.1B ÷ invested capital $21.4B (debt + equity − cash)
    Industry peers: median 12%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    3-yr median margin, range 5%–6%; latest $1.3B = operating cash $1.7B − maintenance capex $447M
    Industry peers: median 14%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 5% of revenue this year, a 6% median across 3 years. Treating stock comp as the real expense it is (less $76M of SBC) leaves $1.2B.

  • Cash-backed
    Cash from ops $1.7B ÷ net income $1.2B
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $33M ÷ Owner Earnings $1.3B
    What this means

    Of $1.3B Owner Earnings, $33M (3%) went back to shareholders, $0 dividends, $33M buybacks. But the buybacks barely exceed stock issued to employees ($76M SBC), net of dilution, little was truly returned. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.44×
    Harvesting
    Capex $447M ÷ depreciation $1.0B
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 3 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Pass
    Revenue ≥ $2B · $28.4B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 4.29×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $12.6B vs $8.2B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.04/share (latest year $1.41), the averaged base the calculator's gate runs on, and book value is $13.11/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing Raised, but not as a competitor

The filing raises AI among its risks, but in other terms (security, regulation, energy or the like), not as a competitor to its product; it frames AI mainly as a capability.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 28, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$11.2B
  • Cash & short-term investments$2.2B
  • Receivables$3.7B
  • Inventory$4.8B
  • Other current assets$463M
Current liabilities$2.5B
  • Debt due within a year$76M
  • Accounts payable$932M
  • Other current liabilities$1.5B
Current ratio4.41×all current assets ÷ what's due · Graham looked for 2×
Quick ratio2.51×stricter: inventory excluded
Cash ratio0.88×strictest: cash alone against what's due
Working capital$8.6Bthe cushion left after near-term bills
Debt due this year vs. cash$76M due · $2.2B cash covered by cash on hand, no refinancing forced · both figures from the Mar 28, 2026 balance sheet
Revenue, latest quarter vs. a year ago+10.7%the freshest read on whether the business is still growing
Current ratio, recent quarters3.4× → 4.4×
Deeper floors
Tangible book value($10.5B)equity stripped of goodwill & intangibles
Net current asset value($8.5B)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$13.0B$451M of it operating leases

From the company's latest filing.

Acquisitions & goodwill

from the balance sheet & the 3-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$22.0B57% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity75%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$1.1Bover 3 years buying other businesses, against $1.1B of capital spent building

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 3-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$76M

    The slice of the business handed to employees in shares this year, 0% of revenue, equal to 3% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition, Income taxes, Credit & receivables, Inventory as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
MDLNMedline Inc.$28.4B26%7.8%10%6%
MMM3M Company$24.9B47%20.2%22%16%
BDXBecton Dickinson and Company$21.8B45%11.6%5%14%
GEHCGE Healthcare Technologies Inc.$20.6B13.4%13%8%
BAXBaxter International Inc.$11.2B40%9.2%6%10%
SOLVSolventum Corporation$8.3B20.7%12%14%
STESteris$5.9B43%16.1%8%12%
WSTWest Pharmaceutical$3.1B35%19.0%19%17%
Group median42%14.7%11%13%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Medline Inc. has delivered.

$
Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · since FY2023−4%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $1.0B on 819M shares outstanding (a weighted basic average, the only count this filer tags); net debt $10.3B. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Medline Inc. (MDLN), the owner's record," https://ownerscorecard.com/c/MDLN, data as of 2026-07-09.

Manual order: ← MDGL its page in the Manual MDLZ →

Industry order: ← MBOT the Medical Devices & Equipment chapter MDT →